NASDAQ:CUE - Cue Biopharma, Inc.
$8.54
 $0.33
+4.02%
4:00PM EDT
2019-04-18
Cue Biopharma Inc, incorporated on December 31, 2014, is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes MHC Class I Program, and MHC Class II Program. The CUE-100 Framework restricts the activity of T cell populations. The CUE-200 Framework enables potent, long-lived anti-tumor T cell responses. The Autoimmune disease therapy protects the healthy cells from immune attack.Immuno-Oncology CUE-100 FrameworkThe CUE-100 Framework restricts the activity of T cell populations. The lead component of CUE-100 Framework is CUE-101 a fusion variant of cytokine Interleukin-2. It treats the unmet clinical needs like human papilloma virus driven cancers. Immuno-Oncology CUE-200 FrameworkThe CUE-200 Framework is designed to enable potent, long-lived T cell responses against the tumor cells that evade the immune system. It aims at stimulating and activating the naive T cells for anti-tumor responsesAutoimmune DiseaseThe Autoimmune disease therapy protects the healthy cells from immune attack by modulating the immune system. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CUE     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 47   203. 85   241. 91  
42 stocks rank:  3. 87 K 1. 44 K 1. 05 K
# analyst opinions:  1. 00   14. 51   13. 97  

quick ratio:  6. 31   5. 27   1. 81  
current ratio:  6. 53   5. 62   2. 25  

target price low:  14. 50   84. 80   115. 21  
target price avg:  14. 50   111. 51   137. 51  
target price high:  14. 50   135. 81   157. 84  
1-yr high:  14. 48   114. 23   138. 78  
last close:  8. 54   87. 66   116. 69  
50-day avg:  7. 44   95. 54   123. 44  
200-day avg:  7. 43   94. 25   121. 11  
1-yr low:  4. 35   72. 78   98. 34  
volume:  151. 57 K 4. 11 M 8. 07 M
50-day avg volume:  102. 94 K 2. 76 M 5. 02 M
200-day avg volume:  99. 32 K 2. 92 M 4. 59 M

1-day return:  4. 02 % -0. 41 % 0. 07 %
this week return:  -2. 73 % -5. 74 % -4. 11 %
12-wk return:  60. 83 % 1. 61 % -0. 05 %
52-wk return:  -39. 41 % 3. 12 % 8. 78 %

enterprise value (EV):  137. 86 M 48. 94 B 114. 64 B
market cap:  177. 07 M 43. 07 B 104. 73 B
EBITDA:  -37. 94 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -3. 63   4. 22   12. 73  
enterprise/revenue (EV/R):  120. 65   63. 17   12. 84  
total revenue:  1. 14 M 10. 62 B 38. 47 B
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -38. 98 M 2. 20 B 4. 20 B

shares outstanding:  20. 73 M 571. 70 M 1. 24 B
shares:  16. 29 M 571. 81 M 1. 23 B
shares short:  1. 43 M 10. 17 M 13. 00 M
shares short prior month:  1. 28 M 9. 54 M 17. 33 M
short ratio:  12. 35   5. 41   3. 28  
short % of float:  8. 16 % 5. 45 % 2. 38 %
total cash/share:  1. 89   11. 14   9. 33  
total cash:  39. 21 M 6. 71 B 7. 15 B
free cash flow:  -17. 33 M 3. 58 B 2. 96 B
operating cash flow:  -26. 41 M 4. 15 B 4. 30 B

book value:  1. 64   12. 78   26. 92  
price/book:  5. 20   3. 06   -1. 74  
gross profits:  -24. 56 M 8. 04 B 34. 86 B
operating margins:  -3386. 71 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  15. 53 % --- ---
1-yr mean volatility:  -0. 07 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 94   2. 40   4. 10  
forward EPS:  -1. 79   3. 97   7. 13  
P/E:  -4. 41   13. 63   22. 72  
forward P/E:  -4. 77   -15. 95   13. 99  
PE/G:  0. 29   -1. 65   -1. 32  
growth:  -15. 12 % 127. 12 % 29. 61 %
earnings high:  -0. 40   1. 00   1. 66  
earnings avg:  -0. 40   0. 77   1. 53  
earnings low:  -0. 40   0. 50   1. 39  
revenue high:  220. 00 K 2. 68 B 10. 78 B
revenue avg:  220. 00 K 2. 59 B 10. 57 B
revenue low:  220. 00 K 2. 49 B 10. 36 B
return on assets:  -43. 07 % -2. 75 % 4. 55 %
return on equity:  -81. 57 % -18. 45 % 5. 46 %
revenue/share:  0. 06   13. 29   55. 46  

beta (1yr vs S&P500):  0. 76   1. 25   0. 93  
sharpe (1yr):  -0. 24   0. 37   0. 70  

held % insiders:  19. 24 % 6. 39 % 3. 38 %
held % institutions:  20. 69 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : CUE
.    + 0.986 =         0.986 :: INITIAL WEIGHT
.  + 144.275 =       145.262 :: inverse volume-to-price addition
.   + 43.288 =        188.55 :: spline projection addition
.    x 5.028 =       948.048 :: 13 weeks' performance factor
.    x 0.779 =       738.066 :: one-year gains+dividend factor
.    x 1.431 =      1056.485 :: industry recommendation factor
.     x 1.09 =      1151.768 :: EV/R factor
.    x 0.996 =      1146.808 :: return on assets factor
.    x 0.992 =      1137.454 :: return on equity factor
.    x 2.839 =      3228.776 :: current ratio factor
.     x 1.09 =      3519.855 :: quick ratio factor
.     x 1.04 =      3659.586 :: short ratio factor
.    x 2.072 =      7581.745 :: price-to-book factor
.    x 1.167 =      8849.262 :: 5-day avg > 200-day avg
.    x 1.166 =     10317.994 :: 5-day avg > 50-day avg
.    x 1.001 =     10328.682 :: 50-day avg > 200-day avg
.    x 2.098 =      21673.94 :: P/E weight
.    x 1.361 =      29489.96 :: PE/G factor
.    x 1.365 =     40263.851 :: beta factor
.    x 0.239 =      9634.794 :: sharpe factor
.    x 1.914 =     18439.319 :: target low factor
.    x 1.278 =     23574.051 :: target mean factor
.    x 1.084 =     25543.426 :: target high factor
.     x 1.31 =     33459.025 :: industry 2-weeks return factor
.    x 0.874 =     29245.692 :: "drift" penalty 4 days ago
.    x 0.984 =     28772.613 :: overall "drift" factor
.    x 0.845 =     24303.675 :: largest single-day jump factor
.    x 0.116 =      2812.925 :: low price factor
.      x 1.0 =      2812.469 :: factor hist industry gain for week 16
.   cubeRoot =        14.115 :: reduced to standardize
.   - 24.518 =         0.472 :: add/subtract for performance
.                      0.472 :: FINAL WEIGHT for NASDAQ:CUE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org